JPM

All articles by JPM

What the healthcare sector was selling at the J.P. Morgan confab
What the healthcare sector was selling at the J.P. Morgan confab
Molly Castle Work and Arthur Allen, KFF Health News
January 22, 2024
11:00 am

After a few years of pandemic slack, the 2024 J.P. Morgan Healthcare Conference regained its full vigor, drawing 8,304 attendees in early January to talk science, medicine, and, especially, money.

JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
Marc Iskowitz
January 11, 2024
9:36 am

The CEOs of Eli Lilly and Novo Nordisk — rivals in the GLP-1 obesity market — addressed nagging questions at the 2024 J.P. Morgan Healthcare Conference.

JPM 2024: Pharma CEOs face a crossroads
JPM 2024: Pharma CEOs face a crossroads
MM+M Staff
January 10, 2024
2:30 pm

The 2024 J.P. Morgan Healthcare Conference is underway and Marc Iskowitz provides an update from on the ground in San Francisco and Jack O’Brien talks with Insilico Medicine’s chief business officer Michelle Chen.

JPM 2024: Renewal is a common theme among pharma CEOs
JPM 2024: Renewal is a common theme among pharma CEOs
Marc Iskowitz
January 9, 2024
9:52 am

Putting a difficult year in the rearview or shedding an older image were common talking points among biopharma CEOs on day one of the JPM 2024 conference.

How biotech companies are standing out during JPM Week
How biotech companies are standing out during JPM Week
Marc Iskowitz
January 8, 2024
4:28 pm

Early-stage biotechs are looking to capture investors’ ‘head and heart’ by working the sidelines of the big event, and by playing the long game.

Stakes are high as biopharma gathers for JPM
Stakes are high as biopharma gathers for JPM
Marc Iskowitz
January 5, 2024
4:25 pm

2023 was a bad year for deal-making. Considering the headwinds, will 2024 be better? Here are some key questions as the JPMorgan Healthcare Conference gets underway.

JPM 2023 Takeouts: iRhythm’s Dan Wilson
JPM 2023 Takeouts: iRhythm’s Dan Wilson
MM+M Staff
January 13, 2023
12:23 pm

Marc Iskowitz speaks with Dan Wilson, EVP of strategy and IR at cardiac monitoring medtech iRhythm, about its push into primary care and more.

GLP-1 wars, an Alzheimer’s credibility deficit and other observations from JPM
GLP-1 wars, an Alzheimer’s credibility deficit and other observations from JPM
Marc Iskowitz
January 13, 2023
5:30 am

A few biopharma trends we’re tracking as the 41st annual JP Morgan Healthcare Conference comes to a close.

JPM 2023 Takeouts: OptimizeRx’s Will Febbo
JPM 2023 Takeouts: OptimizeRx’s Will Febbo
MM+M Staff
January 12, 2023
4:05 pm

Marc Iskowitz speaks with Will Febbo, CEO of point-of-care messaging company OptimizeRx, about the challenge of scaling digital marketing and more.

JPM23 week: Storm prep top of mind for biopharma CEOs
JPM23 week: Storm prep top of mind for biopharma CEOs
Marc Iskowitz
January 12, 2023
5:30 am

Finding alternate paths to growth, despite market turbulence, has been a major talking point for biopharma CEOs during the conference.

  • From Our Partners